Heart Failure Reviews

, Volume 7, Issue 1, pp 29–49 | Cite as

Age-associated Cardiovascular Changes in Health: Impact on Cardiovascular Disease in Older Persons

  • Edward G. Lakatta


In the United States, cardiovascular disease, e.g., atherosclerosis and hypertension, that lead to heart failure and stroke, is the leading cause of mortality, accounting for over 40 percent of deaths in those aged 65 years and above. Over 80 percent of all cardio-vascular deaths occur in the same age group. Thus, age, per se, is the major risk factor for cardiovascular disease. Clinical manifestations and prognosis of these cardiovascular diseases likely become altered in older persons with advanced age because interactions occur between age-associated cardiovascular changes in health and specific pathophysiologic mechanisms that underlie a disease. A fundamental understanding of age-associated changes in cardiovascular structure and function ranging in scope from humans to molecules is required for effective and efficient prevention and treatment of cardiovascular disease in older persons. A sustained effort over the past two decades has been applied to characterize the multiple effects of aging in health on cardiovascular structure and function in a single study population, the Baltimore Longitudinal Study on Aging. In these studies, community dwelling, volunteer participants are rigorously screened to detect both clinical and occult cardiovascular disease and characterized with respect to lifestyle, e.g. exercise habits, in an attempt to deconvolute interactions among lifestyle, cardiovascular disease and the aging process in health. This review highlights some specific changes in resting cardiovascular structure and function and cardiovascular reserve capacity that occur with advancing age in healthy humans. Observations from relevant experiments in animal models have been integrated with those in humans to provide possible mechanistic insight.

aging cardiovascular system heart failure 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441- 1446.Google Scholar
  2. 2.
    Gerstenblith G, Fredricksen J, Yin FCP, et al. Echocardiographic assessment of a normal adult ageing population. Circ 1977;56:273-278.Google Scholar
  3. 3.
    Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991;68:1560-1568.Google Scholar
  4. 4.
    Lakatta EG. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans (point of view). Circ 1993;87:631-636.Google Scholar
  5. 5.
    Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-467.Google Scholar
  6. 6.
    Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990;67:671.Google Scholar
  7. 7.
    Fraticelli A, Josephson R, Danziger R, et al. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am J Physiol 1989;257:H259.Google Scholar
  8. 8.
    Wei JY, Spurgeon HA, Lakatta EG. Excitation- contraction in rat myocardium: alterations with adult aging. Am J Physiol 1984;246:H784.Google Scholar
  9. 9.
    Capasso JM, Malhotra A, Remily RM, et al. Effects of age on mechanical and electrical performance of rat myocardium. Am J Physiol 1983;245:H72.Google Scholar
  10. 10.
    Esler MD, Turner AG, Kaye DM, et al. Ageing effects on human sympathetic neuronal function. Am J Physiol 1995;268:R278-R285.Google Scholar
  11. 11.
    Fleg JL, Tzankoff SP, Lakatta EG. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. J Appl Physiol 1985;59:1033-1039.Google Scholar
  12. 12.
    Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara J, Chapnick S, Reiss K, Olivetti G, Anversa P. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 1996;271:H1215-H1228.Google Scholar
  13. 13.
    Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-2259.Google Scholar
  14. 14.
    Cigola E, Kastura J, Li B, Meggs LG, Anversa P. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 1997;231:363-371.Google Scholar
  15. 15.
    Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgapoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-476.Google Scholar
  16. 16.
    Michel JB, Heudes D, Michel O, Piotevin P, Philippe M, Scalbert E, Corman B, Levy BI. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994;267(1 Pt. 2):R124-135.Google Scholar
  17. 17.
    Fornieri C, Quaglino D, Mori G. Role of the extracellular matrix in age-related modifications of the rat aorta. Arterioscler Thromb 1992;12:1008-1016.Google Scholar
  18. 18.
    Haudenschild CC, Prescott MF, Chobanian AV. Aortic endothelial and subendothelial cells in experimental hypertension and aging. Hypertension 1981;3(Suppl I): I-148-I-153.Google Scholar
  19. 19.
    Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes: morphological and chemical studies. Circ Res 1972;30:301-309.Google Scholar
  20. 20.
    Guyton JR, Lindsay KL, Dao DT. Comparison of aortic intima and inner media in young adult versus aging rats. Am J Pathol 1983;111:234-246.Google Scholar
  21. 21.
    Jenkins GM, Crow MT, Bilato C, Li Z, Ryu W-S, Nater C, Froehlich J, Lakatta EG, Cheng L. The role of MMP-2 in neointima formation following balloon injury in the rat. Circulation 1997 (in press).Google Scholar
  22. 22.
    Galis ZS, Suknova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995;9:874-980.Google Scholar
  23. 23.
    Majesky MW, Lindner V, Twardzik DR, Swchartz SM, Reidy MA. Production of transforming growth factor b1 during repair of arterial injury. J Clin Invest 1991;88:904-910.Google Scholar
  24. 24.
    Li Z, Froehlich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 (mmp-2) in the thickened intima of aged rats. Hypertension 1999;33:116-123.Google Scholar
  25. 25.
    Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME. Aging and atherosclerosis. I Development of myointimal hyperplasmia after endothelial cells injury. J Exp Med 1986;164:1171-1178.Google Scholar
  26. 26.
    Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinsterin C, Lakatta EG, Crow M. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994;75:41-54.Google Scholar
  27. 27.
    Pauly RR, Passaniti A, Crow M, Kinsella JL, Papdopoulos N, Monticone R, Lakatta EG, Martin GR. Experimental models which mimic the differentiation and dedifferentiation of vascular cells. Circulation 1992;86(Suppl 6):III-68-III-73.Google Scholar
  28. 28.
    Sarazani R, Arnaldi G, Takasaki I, Brecher P, Chobanian AV. Effects of hypertension and aging on platelet-derived growth factor and plateletderived growth factor receptor expression in rat aorta and heart. Hypertension 1991;18(Suppl III): III-93-III-99.Google Scholar
  29. 29.
    McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and atherosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet derived growth factor-like activity. J Exp Med 1988;167:163-174.Google Scholar
  30. 30.
    Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA 1982;79:3863-3866.Google Scholar
  31. 31.
    Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92-and 72-kilodalton type IV collagenase are elastases. J Biol Chem 1991;266:7870-7875.Google Scholar
  32. 32.
    McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and atherosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet derived growth factor-like activity. J Exp Med 1988;167:163-174.Google Scholar
  33. 33.
    Nagai J, Metter EJ, Earley CJ, Kemper MK, Becker LC, Lakatta EG, Fleg JL. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998;98:1504-1509.Google Scholar
  34. 34.
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. for the Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and medial thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.Google Scholar
  35. 35.
    Gerstenblith G, Fredricksen J, Yin FCP, et al. Echocardiographic assessment of a normal adult aging population. Circ 1977;56:273.Google Scholar
  36. 36.
    Schulman S, Lakatta EG, Fleg JL, et al. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol 1992;263:H1932.Google Scholar
  37. 37.
    Swinne CJ, Shapiro EP, Lima SD, et al. Ageassociated changes in left ventricular diastolic performance during isometric exercise in normal subjects. Am J Cardiol 1992;69:823.Google Scholar
  38. 38.
    Fleg JL, O'Connor FC, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995;78:890.Google Scholar
  39. 39.
    Fleg JL, Schulman SP, Gerstenblith G, et al. Additive effects of age and silent myocardial ischemia on the left ventricular response to upright cycle exercise. J Appl Physiol 1993;75:499.Google Scholar
  40. 40.
    Yin FCP, Raizes GS, Guarnieri T, et al. Age-associated decrease in ventricular response to haemodynamic stress during beta-adrenergic blockade. Brit Heart J 1978.Google Scholar
  41. 41.
    Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 1993;27(27):1968.Google Scholar
  42. 42.
    Froehlich JP, Lakatta EG, Beard E, et al. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J Mol Cell Cardiol 1978;10:427.Google Scholar
  43. 43.
    Orchard CH, Lakatta EG. Intracellular calcium transients and developed tensions in rat heart muscle. A mechanism for the negative interval-strength relationship. J Gen Physiol 1985;86:637.Google Scholar
  44. 44.
    Lompre AM, Lambert F, Lakatta EG, Schwartz K. Expression of sarcoplasmic reticulum Ca2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 1991;69:1380.Google Scholar
  45. 45.
    Maciel LMZ, Polikar R, Rohrer D, et al. Age-induced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca2+-ATPase of the rat heart. Circ Res 1990;67:230.Google Scholar
  46. 46.
    Tate CA, Taffet GE, Hudson EK, et al. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am J Physiol 1990;258:H431.Google Scholar
  47. 47.
    Effron MB, Bhatnagar GM, Spurgeon HA, Ruano-Arroyo G, Lakatta EG. Changes in myosin isoenzymes, ATPase activity and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine. Circ Res 1987;60:238-245.Google Scholar
  48. 48.
    O'Neill L, Holbrook NJ, Fargnoli J, Lakatta EG. Progressive changes from young adult age to senescence in mRNA for rat cardiac myosin heavy chain genes. Cardioscience 1991;2:1-5.Google Scholar
  49. 49.
    Bhatnagar GM, Walford GD, Beard ES, et al. ATPase activity and force production in myofibrils and twitch characteristics in intact muscle from neonatal, adult, and senescent rat myocardium. J Mol Cell Cardiol 1984;16:203.Google Scholar
  50. 50.
    Koban MU, Moorman AFM, Holtz J, Yacoub MH, Boheler KR. Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence. Cardiovascular Research 1998;37:405-423.Google Scholar
  51. 51.
    Hano O, Bogdanov KY, Sakai M, et al. Reduced threshold for myocardial cell calcium intolerance in the rat heart with aging. Am J Physiol 1995;269:H1607.Google Scholar
  52. 52.
    Lakatta EG. Chaotic behavior of myocardial cells: possible implications regarding the pathophysiology of heart failure. Perspectives Biol Med 1989;32:421- 433.Google Scholar
  53. 53.
    Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circ 1993;88:1456.Google Scholar
  54. 54.
    Pearson JD, Morrell CH, Brant LJ, et al. Ageassociated changes in blood pressure in a longitudinal study of healthy men and women. J Gerontol 1997; 52:M177.Google Scholar
  55. 55.
    Chen C-H, Ting C-T, Lin S-J, et al. Which arterial and cardiac parameters best predict left ventricular mass? Circ 1998;98:422.Google Scholar
  56. 56.
    Chen C-H, Nakayama M, Talbot M, et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. JACC 1999;33:1602.Google Scholar
  57. 57.
    Nussbacher A, Gerstenblith G, O'Connor F, et al. Hemodynamic effects of unloading the old heart. Am J Physiol 1999;277:H1863.Google Scholar
  58. 58.
    Iwase S, Mano T, Watanabe T, Saito M, Kobayashi F. Age-related changes of sympathetic outflow to muscles in humans. J Geront 1991;46:M1-M5.Google Scholar
  59. 59.
    Hogikyan RV, Supiano MA. Arterial a-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol 1994;266(Endocrinol Metab 29):E717-E724.Google Scholar
  60. 60.
    Sudhir K, Esler MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997;30:1538-1543.Google Scholar
  61. 61.
    Xiao R-P, Spurgeon HA, O'Connor F, Lakatta EG. Ageassociated changes in b-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest 1994;94:2051.Google Scholar
  62. 62.
    Scarpace PJ. Forskolin activation of adenylate cyclase in rat myocardium with age: effects of guanine nucleotide analogs. Mech Ageing Dev 1990;52:169.Google Scholar
  63. 63.
    Xiao R-P, Tomhave ED, Xiangwu J, Boluyt MO, Cheng H, Lakatta EG, Koch WJ. Age-associated reductions in cardiac β1-and β2-adrenoceptor responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 1998;101:1273-1282.Google Scholar
  64. 64.
    Jiang MT, Moffat MP, Narayanan N. Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle. Circ Res 1993;72:102.Google Scholar
  65. 65.
    Sakai M, Danzinger RS, Staddon JM, Lakatta EG, Hansford RG. Decrease with senescence in the norepinephrine-induced phosphorylation of myofilament proteins in isolated rat cardiac myocytes. J Mol Cell Cardiol 1989;21:1327-1336.Google Scholar
  66. 66.
    Fleg JL, Lakatta EG. Role of muscle loss in the ageassociated reduction in Vo2 max. J Appl Physiol 1988;65(3):1147-1151.Google Scholar
  67. 67.
    Schulman SP, Fleg JL, Goldberg AP, et al. Continuum of cardiovascular performance across a broad range of fitness levels in healthy older men. Circ 1996;94:359.Google Scholar
  68. 68.
    Tanaka H, DeSouza CA, Seals DR. Absence of agerelated increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998;18:127-132.Google Scholar
  69. 69.
    National Center for Health Statistics Vital statistics of the United States, 1988, Vol. II Mortality, Part A, Tables 1-27, 1-129. National Center for Health Statistics, Rockville, MD, 1991.Google Scholar
  70. 70.
    Lakatta EG, Weisfeldt ML, Gerstenblith G. The aging heart: Structure, function, and disease. In: E. Braunwald ed. Heart Disease. A Textbook of Cardiovascular Medicine, 5th edition. WB Saunders, NY. Chapter 50, p 1687, 1996.Google Scholar
  71. 71.
    Younes A, Boluyt MO, O'Neill L, et al. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol 1995;269 (Heart Circ Physiol 38):H1003-H1008.Google Scholar
  72. 72.
    Caffrey JL, Boluyt MO, Younes A, et al. Aging, cardiac proenkephalin mRNA, enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol 1994;26:701-711.Google Scholar
  73. 73.
    Boluyt MO, Younes A, Caffrey JL, O'Neill L, Barron BA, Crow MT, Lakatta EG. Age-associated increase in rat cardiac opioid production. Am J Physiol 1993;265:H212-H218.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Edward G. Lakatta
    • 1
  1. 1.Laboratory of Cardiovascular Science, Gerontology Research CenterNational Institute on Aging, National Institute of HealthUSA

Personalised recommendations